Two coauthors of a new study discuss their findings about nearly 170 facilities in the southwestern US selling unproven therapies—and what should be done about them.

More than one-fifth of individuals treated with the genetically modified virus survived at least three years.

Combining genomic, clinical, and patient-reported data, the Metastatic Breast Cancer Project provides a unique resource for the cancer community.

The legislation removes restrictions for seriously ill patients to access experimental treatments that have not received FDA approval.

With few resources and hesitant investors, basic scientists must rely on clinicians, patient advocates, and their own keen eye for biological connections.

The change should allow patients with fatal illnesses easier access to experimental drugs, but gaining permission from drug companies remains the biggest challenge.

Researchers pinpoint the source of the current Ebola outbreak in West Africa to 2-year-old boy who died in southern Guinea.

The ALS Association has raised more than $100 million in donations through a charity campaign that went viral. How should that money be spent?

Tailoring ethical oversight to participant-led research